NXG · NXG NextGen Infrastructure Income Fund
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-08-24 | Alban John |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported price in Column 4 is a weighted average price. These shares were bought in multiple transactions on 08/24/2026, prices ranged from $55.23 to $55.25 per share, inclusive. Includes 11 shares of common stock acquired through an Automatic Dividend Reinvestment Plan (DRIP). |
Common Stock
|
500 |
| 2026-07-20 | Alban John |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported price in Column 4 is a weighted average price. These shares were bought in multiple transactions on 07/20/2026, prices ranged from $59.01 to $59.02 per share, inclusive. Includes 77 shares of common stock acquired through an Automatic Dividend Reinvestment Plan (DRIP). |
Common Stock
|
500 |
| 2026-05-07 | Sunderland Todd |
Insider |
Buy↑
Filing footnotes — Common Shares of Beneficial Interest (Direct)
Shares were acquired pursuant to the exercise of rights to acquire common shares in the Fund's transferrable rights offering, which expired on April 30, 2026, at the subscription price of $58.45. The number of common shares acquired was confirmed to exercising rights holders on May 7, 2026. |
Common Shares of Beneficial Interest
|
802 |
| 2026-05-07 | Mullins Andrea |
Director |
Buy↑
Filing footnotes — Common Shares (Direct)
Shares were acquired pursuant to the exercise of rights to acquire common shares in the Fund's transferrable rights offering, which expired on April 30, 2026, at the subscription price of $58.45. The number of common shares acquired was confirmed to exercising rights holders on May 7, 2026. Includes 30.0538 shares of common stock acquired through an Automatic Dividend Reinvestment Plan (DRIP). |
Common Shares
|
346 |
| 2026-05-07 | Sunderland Todd |
Insider |
Buy↑
Filing footnotes — Common Shares of Beneficial Interest (Indirect)
Shares were acquired pursuant to the exercise of rights to acquire common shares in the Fund's transferrable rights offering, which expired on April 30, 2026, at the subscription price of $58.45. The number of common shares acquired was confirmed to exercising rights holders on May 7, 2026. Includes 12.975 shares of common stock acquired through an Automatic Dividend Reinvestment Plan (DRIP). |
Common Shares of Beneficial Interest
(I)
|
27 |
| 2026-05-07 | Musgrave John M. |
CEO & President |
Buy↑
Filing footnotes — Common Shares (Direct)
Shares were acquired pursuant to the exercise of rights to acquire common shares in the Fund's transferrable rights offering, which expired on April 30, 2026, at the subscription price of $58.45. The number of common shares acquired was confirmed to exercising rights holders on May 7, 2026. Includes 7.7363 shares of common stock acquired through an Automatic Dividend Reinvestment Plan (DRIP). |
Common Shares
|
134 |
| 2026-05-07 | Nelson Blake |
Chief Financial Officer |
Buy↑
Filing footnotes — Common Shares of Beneficial Interest (Direct)
Shares were acquired pursuant to the exercise of rights to acquire common shares in the Fund's transferrable rights offering, which expired on April 30, 2026, at the subscription price of $58.45. The number of common shares acquired was confirmed to exercising rights holders on May 7, 2026. |
Common Shares of Beneficial Interest
|
222 |
| 2026-03-10 | Sunderland Todd |
Insider |
Buy↑
Filing footnotes — Common Shares of Beneficial Interest (Direct)
The reported price in Column 4 is a weighted average price. These shares were bought in multiple transactions on 03/10/2026, prices ranged from $51.96 to $52.78 per share, inclusive. Includes 27.996 shares of common stock acquired through an Automatic Dividend Reinvestment Plan (DRIP). |
Common Shares of Beneficial Interest
|
2,000 |
| 2026-03-10 | Musgrave John M. |
CEO & President |
Buy↑
|
Common Shares
|
400 |
| 2026-02-06 | Mullins Andrea |
Director |
Buy↑
Filing footnotes — Common Shares (Direct)
Includes 9.1084 shares of common stock acquired through an Automatic Dividend Reinvestment Plan (DRIP). |
Common Shares
|
155 |
| 2026-01-08 | Nelson Blake |
Chief Financial Officer |
Buy↑
|
Common Shares of Beneficial Interest
|
326 |
| 2025-11-05 | Alban John |
Director |
Buy↑
|
Common Stock
|
1,000 |
| 2025-08-20 | Nelson Blake |
Chief Financial Officer |
Buy↑
Filing footnotes — Common Shares of Beneficial Interest (Direct)
Shares were acquired pursuant to the exercise of rights to acquire common shares in the Fund's transferrable rights offering, which expired on August 13, 2025, at the subscription price of $44.92. The number of common shares acquired was confirmed to exercising rights holders on August 20, 2025, following the pro-ration and allocation of shares pursuant to the over-subscription privilege. |
Common Shares of Beneficial Interest
|
200 |
| 2025-08-20 | Sunderland Todd |
Insider |
Buy↑
Filing footnotes — Common Shares of Beneficial Interest (Indirect)
Shares were acquired pursuant to the exercise of rights to acquire common shares in the Fund's transferrable rights offering, which expired on August 13, 2025, at the subscription price of $44.92. The number of common shares acquired was confirmed to exercising rights holders on August 20, 2025, following the pro-ration and allocation of shares pursuant to the over-subscription privilege. Includes 52.048 shares of common stock acquired through an Automatic Dividend Reinvestment Plan (DRIP). |
Common Shares of Beneficial Interest
(I)
|
37 |
| 2025-08-20 | Mullins Andrea |
Director |
Buy↑
Filing footnotes — Common Shares of Beneficial Interest (Direct)
Shares were acquired pursuant to the exercise of rights to acquire common shares in the Fund's transferrable rights offering, which expired on August 13, 2025, at the subscription price of $44.92. The number of common shares acquired was confirmed to exercising rights holders on August 20, 2025, following the pro-ration and allocation of shares pursuant to the over-subscription privilege. |
Common Shares of Beneficial Interest
|
375 |
| 2025-08-20 | Sunderland Todd |
Insider |
Buy↑
Filing footnotes — Common Shares of Beneficial Interest (Direct)
Shares were acquired pursuant to the exercise of rights to acquire common shares in the Fund's transferrable rights offering, which expired on August 13, 2025, at the subscription price of $44.92. The number of common shares acquired was confirmed to exercising rights holders on August 20, 2025, following the pro-ration and allocation of shares pursuant to the over-subscription privilege. Includes 20.473 shares of common stock acquired through an Automatic Dividend Reinvestment Plan (DRIP). |
Common Shares of Beneficial Interest
|
150 |
| 2024-12-27 | Sunderland Todd |
Insider |
Sell↓
Filing footnotes — Common Shares of Beneficial Interest (Indirect)
Includes 35.83 shares of common stock acquired through an Automatic Dividend Reinvestment Plan (DRIP). |
Common Shares of Beneficial Interest
(I)
|
30 |
| 2024-09-16 | Alban John |
Director |
Sell↓
|
Common Stock
|
1,233 |
| 2024-09-09 | Mullins Andrea |
Director |
Buy↑
|
common shares of beneficial interest
|
480 |
| 2024-07-23 | Swank Jerry V |
Insider |
Exercise↑
|
common shares of beneficial interest
|
11,300 |
| 2024-07-23 | Sunderland Todd |
Insider |
Buy↑
|
Common Shares of Beneficial Interest
|
87 |
| 2024-07-15 | Sunderland Todd |
Insider |
Buy↑
|
Common Shares of Beneficial Interest
(I)
|
956 |
| 2023-12-05 | Swank Jerry V |
Insider |
Buy↑
|
Common Shares
|
8,900 |
| 2023-11-07 | Sunderland Todd |
Insider |
Buy↑
|
Common Shares
|
100 |
| 2023-11-06 | Nelson Blake |
Chief Financial Officer |
Buy↑
|
Common Shares
|
200 |
| 2023-11-06 | Nelson Blake |
Chief Financial Officer |
Buy↑
|
Common Shares
|
100 |
| 2023-09-06 | Swank Jerry V |
Insider |
Buy↑
|
Common Shares
|
10,000 |
| 2023-09-05 | Swank Jerry V |
Insider |
Buy↑
Filing footnotes — Common Shares (Direct)
This transaction was executed in multiple trades at prices ranging from $40.00 to $40.44. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
Common Shares
|
15,000 |
| 2023-02-27 | Alban John |
Director |
Buy↑
Filing footnotes — Common Shares (Direct)
This transaction was executed in multiple trades at prices ranging from $39.00 to $39.55. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
Common Shares
|
810 |
| 2023-02-24 | Alban John |
Director |
Buy↑
Filing footnotes — Common Shares (Direct)
This transaction was executed in multiple trades at prices ranging from $38.60 to $38.95. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
Common Shares
|
190 |